See also this year's filing and all EDGAR filings for this company.
PDF Report 0001061983_2013_Cytokinetics_INC.pdf
Logs
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'0120 - Statement - Statements of Comprehensive Loss': 14, '01201 - Statement - Statements Of Comprehensive Loss Alternative': 2}} |
Graph
Absolute values for 0001061983, Cytokinetics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 76,427,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 997,000 |
| 3 | remainder_Assets | 127,000 |
| 4 | LiabilitiesCurrent | 7,105,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 361,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 156,381,000 |
| 9 | ResearchAndDevelopmentExpense | 488,115,000 |
| 10 | remainder_Expenses | 3,560,000 |
| 11 | remainder_Revenues | 177,635,000 |
| 12 | remainder_NetIncome | 21,541,000 |
| 13 | remainder_ComprehensiveNetIncome | 18,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 77,551,000 |
| 1 | Liabilities | 7,466,000 |
| 2 | Expenses | 648,056,000 |
| 3 | Revenues | 177,635,000 |
| 4 | StockholdersEquity | 70,085,000 |
| 5 | NetIncome | -448,880,000 |
| 6 | ComprehensiveNetIncome | -448,871,000 |
| 7 | BaseVar | 466,133,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -6.97 |
| 9 | EconomicCapitalRatio | 0.0291 |
Edgar->Model Mapping
Feature Distribution
Change over Time
